(Q37783637)

23 August 2017

title

Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases? (English)

1 reference

Beatriz Gomez Perez-Nievas

23 August 2017

author

object named as

Beatriz G Pérez-Nievas

series ordinal

2

0 references

Juan Carlos Leza

object named as

Juan C Leza

series ordinal

3

0 references

author name string

Borja García-Bueno

series ordinal

1

1 reference

23 August 2017

publication date

27 August 2010

1 reference

The International Journal of Neuropsychopharmacology

23 August 2017

published in

1 reference

23 August 2017

volume

13

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1411-1429

1 reference

Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Association study of Wnt signaling pathway genes in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Neuronal expression of cyclooxygenase-2, a pro-inflammatory protein, in the hippocampus of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Association between BanI genotype and increased phospholipase A2 activity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Increased nitric oxide radicals in postmortem brain from patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress hormone-related psychopathology: pathophysiological and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Inflammation in central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Acute neuronal injury, excitotoxicity, and the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A family based study of the genetic association between the PLA2G4D gene and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cannabinoids: a new group of agonists of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

An inflammatory review of glucocorticoid actions in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The stressed CNS: when glucocorticoids aggravate inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Valproic acid attenuates inflammation in experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Serotonin modulation of cerebral glucose metabolism in depressed older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Signaling the brain in systemic inflammation: the role of perivascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Allelic association study between phospholipase A2 genes and bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Protective and damaging effects of stress mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

No association between the PPARG gene and schizophrenia in a British population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress, learned helplessness, and brain interleukin-1 beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Prostaglandins and sickness behavior: old story, new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The cholinergic anti-inflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Major depression and activation of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Short and long-term immunosuppressive effects of clozapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Schizophrenia as a disorder of neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The effects of psychological stress on plasma interleukin-6 activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Altered dendritic spine density in animal models of depression and in response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Haloperidol downregulates phospholipase A(2) signaling in rat basal ganglia circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

21 January 2018

Prostaglandin E synthase

2 references

https://api.crossref.org/works/10.1017%2FS1461145710000970

21 January 2018

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Cannabis and psychosis: search of a causal link through a critical and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Effects of lithium on brain glucose metabolism in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress: metaplastic effects in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Pro12Ala polymorphism in PPARgamma2 associated with depression in Chinese nonagenarians/centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Theories of schizophrenia: a genetic-inflammatory-vascular synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Microglia as mediators of inflammatory and degenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Increased platelet phospholipase A2 activity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The endocannabinoid system and neurogenesis in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Intrinsic regulation of brain inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Role of cannabis and endocannabinoids in the genesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Agonists for Neurological Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Adult neurogenesis, mental health, and mental illness: hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: role in LH behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Functional neuroimaging studies of depression: the anatomy of melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Neuroinflammation in schizophrenia-related psychosis: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Stress and the brain: from adaptation to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Ajulemic acid: A novel cannabinoid produces analgesia without a "high"

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Neurotrophins and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Positron emission tomography studies of abnormal glucose metabolism in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

A mechanism converting psychosocial stress into mononuclear cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

Evidence for activation of microglia in patients with psychiatric illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

No association between the PTGS2/PLA2G4A locus and schizophrenia in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

A genetic study of two calcium-independent cytosolic PLA2 genes in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Cytosolic PLA2 genes possibly contribute to the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

The PPARD gene may be associated with schizophrenia in a Chinese population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. A Nested Case-Control Study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Inflammation, glutamate, and glia in depression: a literature review.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Ban I Polymorphism of the Cytosolic Phospholipase A 2 Gene and Mood Disorders in the Korean Population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

A case-control study of genetic association of the PLA2G4A gene with schizophrenia in a Chinese population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Elevated plasma prostaglandin E2 levels in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Allelic association analysis of phospholipase A2 genes with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000970

7 January 2021

10.1017/S1461145710000970

Identifiers

DOI

1 reference

23 August 2017

1 reference